(NASDAQ:HSDT), NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that on July 7, 2025, Helius received formal notice from the Nasdaq Hearings Panel of the Nasdaq Stock […]
(TSX:SVA),(OTC US:SEOVF),(Other OTC:SEOVF),(XETRA:PSH.DE),(Frankfurt:PSH),(NASDAQ:ELDN), LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) — Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) to evaluate Eledon's immunosuppressive agent tegoprubart (AT-1501) in Sernova's ongoing Phase 1/2 clinical trial of its Cell Pouch Bio-hybrid Organ in patients
(NasdaqGM:KBSX), BOULDER, CO, July 09, 2025 (GLOBE NEWSWIRE) — FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced it has approved plans to expand its fulfillment facility located in Garden Grove, California, adding an additional 5,424 square feet, or 155
Indianapolis, Indiana, July 09, 2025 (GLOBE NEWSWIRE) — TRIMEDX―a leading independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity― is proud to announce it has been ranked 30th on the 2025 list of Top 100 Inspiring Workplaces in North America by the Inspiring Workplaces Group. In addition, TRIMEDX
(Other OTC:MDWK),(OTC US:MDWK), GREEN COVE SPRINGS, Fla., July 09, 2025 (GLOBE NEWSWIRE) — MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its subsidiary, Two Trees Beverage Company (“Two Trees”), received three 2025 SIP Awards, including a Silver Medal and an
(NYSE:LOB), WILMINGTON, N.C., July 09, 2025 (GLOBE NEWSWIRE) — Live Oak Bancshares, Inc. (NYSE: LOB) today announced that it will report its second quarter 2025 financial results after U.S. financial markets close on Wednesday, July 23, 2025. In conjunction with this announcement, Live Oak will host a conference call to discuss the company's financial results
(NASDAQ:ADIL), GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the filing of an update to the provisional patent application for AD04 which was filed in July
(TSX:STN),(NYSE:STN), EDMONTON, Alberta, July 09, 2025 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec, a global leader in sustainable design and engineering, will release its second quarter 2025 financial results after markets close on Wednesday, August 13, 2025. On Thursday, August 14, 2025, at 7:00 AM Mountain Time (9:00 AM Eastern Time), Gord Johnston, president and chief
(NasdaqGM:AMOD),(NASDAQ:AMODW), CORNELIUS, N.C., July 09, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (NASDAQ: AMOD), a pioneer in AI-powered retail technology and data-driven innovation, is pleased to announce the issuance of U.S. Patent No. 12,354,121, effective July 8, 2025. This patent strengthens Alpha Modus's intellectual property position in the fast-evolving in-store technology space, particularly in
(NasdaqGM:SLXN), Grand Cayman, Cayman Islands, July 09, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced new positive preclinical data demonstrating SIL204's significant efficacy in human lung cancer cell lines. The Company is also pleased to announce